Promote a Clinical Trial


A Study of LY2801653 in Advanced Cancer

The purpose of this study is to determine a safe dose of LY2801653 to be given to patients with advanced cancer and to determine any side effects that may be associated with LY2801653 in this patient population. Efficacy measures will be used to assess the activity of LY2801653 in this patient population.

Sponsored by: Eli Lilly and Company